Category: Uncategorized

LEAD Coalition Supports Passage of the CHANGE Act

Posted on

Tweet
Share
Share
Pin
0 Shares

On September 9, 400 LEAD Coalition member organizations and allies wrote to Congress in support of S. 1799 / H.R. 3501, informally called The Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act. The CHANGE Act will strengthen dementia detection and, in turn, catalyze improved care, promote health equity, and accelerate science to prevent, […]

Tweet
Share
Share
Pin
0 Shares

LEAD Coalition welcomes new federal policy director, Dr. Courtney Wallin

Posted on

Tweet
Share
Share
Pin
0 Shares

Leaders Engaged on Alzheimer’s Disease (LEAD Coalition) is pleased to announce the appointment of Dr. Courtney Wallin as our new Federal Policy Director, beginning on June 10.  In this role, Dr. Wallin will work alongside the Executive Director (Ian Kremer, JD) to build and leverage consensus on federal public policies relevant to Alzheimer’s disease and related […]

Tweet
Share
Share
Pin
0 Shares

LEAD Coalition submits public comment letter to FDA on study of sex differences

Posted on

Tweet
Share
Share
Pin
0 Shares

Today, 303 LEAD Coalition member organizations and allies sent a joint public comment letter to the U.S. Food and Drug Administration (FDA) regarding its draft guidance for the study of sex differences in the clinical evaluation of medical products (Docket No. FDA-2024-D-4245). The letter, co-led by the Society for Women’s Health Research, supports the draft […]

Tweet
Share
Share
Pin
0 Shares